SE9203857D0 - Use of an enantiomeric dihydropyridine - Google Patents

Use of an enantiomeric dihydropyridine

Info

Publication number
SE9203857D0
SE9203857D0 SE9203857A SE9203857A SE9203857D0 SE 9203857 D0 SE9203857 D0 SE 9203857D0 SE 9203857 A SE9203857 A SE 9203857A SE 9203857 A SE9203857 A SE 9203857A SE 9203857 D0 SE9203857 D0 SE 9203857D0
Authority
SE
Sweden
Prior art keywords
treatment
dihydropyridine
enantiomeric
alchohol
abstinence
Prior art date
Application number
SE9203857A
Other languages
English (en)
Swedish (sv)
Inventor
B Samuelssoon
M Nordlander
P Thoren
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9203857A priority Critical patent/SE9203857D0/xx
Publication of SE9203857D0 publication Critical patent/SE9203857D0/xx
Priority to PCT/SE1993/001071 priority patent/WO1994014441A1/en
Priority to AU58253/94A priority patent/AU5825394A/en
Priority to IS4109A priority patent/IS4109A/is

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE9203857A 1992-12-22 1992-12-22 Use of an enantiomeric dihydropyridine SE9203857D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9203857A SE9203857D0 (sv) 1992-12-22 1992-12-22 Use of an enantiomeric dihydropyridine
PCT/SE1993/001071 WO1994014441A1 (en) 1992-12-22 1993-12-15 Use of an enantiomeric dihydropyridine
AU58253/94A AU5825394A (en) 1992-12-22 1993-12-15 Use of an enantiomeric dihydropyridine
IS4109A IS4109A (is) 1992-12-22 1993-12-20 Notkun handhverfs díhýdrópýridíns

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9203857A SE9203857D0 (sv) 1992-12-22 1992-12-22 Use of an enantiomeric dihydropyridine

Publications (1)

Publication Number Publication Date
SE9203857D0 true SE9203857D0 (sv) 1992-12-22

Family

ID=20388202

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9203857A SE9203857D0 (sv) 1992-12-22 1992-12-22 Use of an enantiomeric dihydropyridine

Country Status (4)

Country Link
AU (1) AU5825394A (xx)
IS (1) IS4109A (xx)
SE (1) SE9203857D0 (xx)
WO (1) WO1994014441A1 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1343501A4 (en) * 2000-11-21 2004-12-15 Howard Zik USE OF 1,4-DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS FOR THE TREATMENT OF NEUROLOGICAL INVOLVEMENTS ATTRIBUTABLE TO HERPES VIRUS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
DE3806277A1 (de) * 1988-02-27 1989-09-07 Troponwerke Gmbh & Co Kg Verwendung von 1,4-dihydropyridin-derivaten
EP0557290A1 (en) * 1990-08-23 1993-09-01 The Children's Medical Center Corporation Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss
JPH06502155A (ja) * 1990-10-30 1994-03-10 ザ　ウエルカム　ファウンデーション　リミテッド 脱髄性疾患の処置方法

Also Published As

Publication number Publication date
WO1994014441A1 (en) 1994-07-07
AU5825394A (en) 1994-07-19
IS4109A (is) 1994-06-23

Similar Documents

Publication Publication Date Title
ES479474A1 (es) Procedimiento para la obtencion de una composicion a base dederivados de la piridina de accion cerebral.
IT9048260A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
ATE84412T1 (de) Pharmazeutisches praeparat mit verzoegerter abgabe eines dihydropyridins und eines betaadrenorezeptor-antagonisten und herstellungsverfahren dessen.
CA2149242A1 (en) Quinuclidine Derivative for Treatment of Inflammatory and Gastrointestinal Disorders
HUP9700603A1 (hu) Gyógyászati készítmény véralvadási zavarok kezelésére
FR2694290B1 (fr) Nouvelles phénylimidazolidines éventuellement substituées, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant.
EP0765160A4 (xx)
CA2129995A1 (en) Piperidinyl thiacyclic derivatives
IT9048261A0 (it) Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
IT8448983A1 (it) Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
IT9020020A0 (it) "n,n'-ditrimetossibenzoilpiperazine 2-sostituite, procedimento per la loro preparazione e composizioni terapeutiche che le contengono
SE9203857D0 (sv) Use of an enantiomeric dihydropyridine
PL310950A1 (en) Novel imidazole quinoxalinones, method of obtaining them and their application
FR2749586B1 (fr) Nouveaux dispositifs destines a l'administration transdermique de la trimegestone, leur procede de preparation et leur application a titre de medicaments
EA199900862A1 (ru) Способ лечения сосудистых нарушений
AU686976B2 (en) Isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1, 4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylate
AU7720587A (en) Substituted hexahydroarylquinolizines
RU2001104929A (ru) Способ лечения рассеянного склероза
AR002736A1 (es) Uso de ester 3-metil-5-etilico de acido 2,6-dimetil-4-(2,3-diclorofenil-1,4 -dihidropiridin-3,5-dicarboxilico (felodipina) para fabricar un medicamento ypreparacion farmaceutica para el tratamiento de la disfuncion cerebral.
IL96161A0 (en) Application of n-methyl-2-(3-pyridyl)tetrahydrothiopyran-2-carbothioamide 1-oxide to the preparation of medicinal products intended for the treatment of coronary insufficiency
CA2080040A1 (en) Methods for preventing mycobacterial infections by administration of rifabutin
PT80521B (en) Process for the preparation of esters of the 1,4-dihydro-2,6-dimethyl-3-(alcoxicarbonyl or alcoxialcoxicarbonyl)-4-(substituted phenyl) pyridin-5-carboxylic acid of stereochemical isomers and pharmaceutically acceptable salts thereof
RU96124465A (ru) Способ лечения стойких дезадаптационных психовегетативных расстройств